MRI-guided biopsy in the diagnosis of prostate cancer (again)

The results of the so-called PRECISION trial were just published in the New England Journal of Medicine this morning. … READ MORE …

“Getting off biopsy train in prostate cancer”

“Getting off biopsy train in prostate cancer” is the title of the latest article by Howard Wolinsky (a long-time active active surveillance patient) on the MedPage Today web site. We recommend it to your attention. … READ MORE …

“Is prostate cancer screening right for you?”

The following infographic was also issued today by the U.S. Preventive Services Task Force (USPSTF) and offers guidance as to the appropriateness of prostate cancer screening for an average, 55- to 69-year-old American male with no specific, known risk factors for prostate cancer: … READ MORE …

The potential of shear wave elastography — an update

First and foremost, we would like to thank Prof. Ghulam Nabi of the University of Dundee for providing us with a preprint of the full text of his team’s article on transrectal SWE within about 30 seconds of receiving our request! That’s a record! … READ MORE …

Long-term data on active surveillance from MSKCC

A presentation at the upcoming annual meeting of the American Urological Association (AUA) will provide data on outcomes of men initially managed on active surveillance at Memorial Sloan-Kettering Cancer Center (MSKCC) in New York over the past 17 years. … READ MORE…

Are African American men good candidates for active surveillance?

Data from what appears to be one of the largest registry studies to date suggest that race does not increase risk for upstaging or upgrading in men who are eligible candidates for active surveillance. … READ MORE …

Active surveillance in men with Gleason 3 + 4 = 7 prostate cancer at diagnosis

A critical question for men with favorable intermediate-risk prostate cancer (based primarily on a Gleason score of 3 + 4 = 7) can often be, “How safe would it be for me to go on active surveillance for a while after initial diagnosis?” … READ MORE …